Translate
Ovid Therapeutics Inc
About
Ovid Therapeutics Inc (NASDAQ:OVID) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
Mar 18 2026
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 18 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
Feb 25 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Dec 18 2025
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
Recent Videos
Ovid Therapeutics Raises $53.9M: Shareholder Concerns?
Apr 20, 2026
OVID STOCK : STRONG RECOVERY | OVID THERAPEUTICS STOCK
Apr 19, 2026
Ovid Therapeutics KCC2 Deep Dive R&D Event | April 14, 2026
Apr 16, 2026
18 March 26. Biotech Stock News. Daily Recap2 #English #Shorts $XBI #trading #biotechnews #dailynews
Mar 18, 2026